Outsourcing in drug development: Live from J.P. Morgan Week

In the latest episode of Molecule to Market, Executive Vice President of Inizio Biotech, Dean McAlister joins Chris Garabedian – CEO, Xontogeny and Portfolio Manager, PXV Fund – and Catherine Hunter – Head of Business Development at ramarketing – to explore the outsourcing space of the global drug development sector, live from JPM’s Annual Healthcare Conference 2026.  

What industry leaders are really saying after JPM 2026 

Hear from the experts who have seen multiple cycles and understand the difference between noise and signal. Dean, Chris, and Catherine discuss confidence levels, what dominated conversations in San Francisco this year, and where capital and opportunity are genuinely moving. 

Listen to the Molecule to Market podcast 

Go beyond the headlines and hear first-hand perspectives from leaders shaping decisions across biotech, investment, and outsourcing. Tune in to the latest Molecule to Market episode for grounded insight into what JPM 2026 revealed and what it means for the year ahead. 

Listen to the podcast.